Martin, Sebastian
Wendlinger, Lennard
Zitti, Béatrice
Hicham, Mehdi
Postupalenko, Viktoriia
Marx, Léo
Giordano-Attianese, Greta
Cribioli, Elisabetta
Irving, Melita
Litvinenko, Alexandra
Faizova, Radmila
Viertl, David
Schottelius, Margret http://orcid.org/0000-0002-1928-6913
Funding for this research was provided by:
University of Lausanne
Article History
Received: 21 May 2024
Accepted: 19 August 2024
First Online: 28 August 2024
Declarations
:
: All animal experiments were conducted in compliance either with the ARRIVE guidelines and according to the Swiss regulations (cantonal authorizations VD-3781 and VD-3595) and the guidelines of the Lausanne University Hospital.
: Not applicable.
: The authors LM and VP are employees of Debiopharm which is IP holder for the AbYlink technology. Materials for the antibody conjugation were provided from Debiopharm under MTA.